Positron emission tomography/computed tomography: Protocol issues and options

Seminars in Nuclear Medicine

Volumn 36, Issue 2, 2006, Pages 157-168

  Blodgett, Todd M ^a   McCook, Barry M ^a   Federle, Michael P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ABDOMINAL CANCER; ARTIFACT; BREATHING MECHANICS; CANCER DIAGNOSIS; CLINICAL PROTOCOL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC REASONING; DIAGNOSTIC VALUE; DOSE RESPONSE; HUMAN; IMAGING; PATIENT POSITIONING; PELVIS CANCER; POSITRON EMISSION TOMOGRAPHY; QUALITATIVE ANALYSIS; REVIEW;

ARTIFACTS; CONTRAST MEDIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644616933     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2005.12.004     Document Type: Review

References (55)

1. C.C. Meltzer, J.D. Luketich, D. Friedman Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography Clin Nucl Med 25 2000 882 887
2. M. Martinelli, D. Townsend, C. Meltzer Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility Clin Positron Imaging 3 2000 161
3. P.G. Kluetz, C.C. Meltzer, V.L. Villemagne Combined PET/CT imaging in oncology. Impact on patient management Clin Positron Imaging 3 2000 223 230
4. P. Kluetz, V.V. Villemagne, C. Meltzer 20. The Case for PET/CT. Experience at the University of Pittsburgh Clin Positron Imaging 3 2000 174
5. T. Beyer, D.W. Townsend, T. Brun A combined PET/CT scanner for clinical oncology J Nucl Med 41 2000 1369 1379
6. T. Beyer, G. Antoch, S. Muller Acquisition protocol considerations for combined PET/CT imaging J Nucl Med 45 suppl 1 2004 25S 35S
7. G. Antoch, L.S. Freudenberg, T. Beyer To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT J Nucl Med 45 suppl 1 2004 56S 65S
8. G. Antoch, L.S. Freudenberg, J. Stattaus Whole-body positron emission tomography-CT Optimized CT using oral and IV contrast materials AJR Am J Roentgenol 179 2002 1555 1560
9. T. Beyer, G. Antoch, A. Bockisch, J. Stattaus Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT J Nucl Med 46 2005 429 435
10. T. Beyer, G. Antoch, T. Blodgett Dual-modality PET/CT imaging the effect of respiratory motion on combined image quality in clinical oncology Eur J Nucl Med Mol Imaging 30 2003 588 596
11. R.L. Baron, J.H. Oliver 3rd, G.D. Dodd 3rd Hepatocellular carcinoma evaluation with biphasic, contrast-enhanced, helical CT Radiology 199 1996 505 511
12. B.A. Birnbaum, J.E. Jacobs, P. Ramchandani Multiphasic renal CT comparison of renal mass enhancement during the corticomedullary and nephrographic phases Radiology 200 1996 753 758
13. B.A. Birnbaum, J.E. Jacobs, D. Yin Hepatic enhancement during helical CT A comparison of moderate rate uniphasic and biphasic contrast injection protocols AJR Am J Roentgenol 165 1995 853 858
14. S.P. Blake, K. Weisinger, M.B. Atkins Liver metastases from melanoma Detection with multiphasic contrast-enhanced CT Radiology 213 1999 92 96
15. G. Brancatelli, M.P. Federle, L. Grazioli Focal nodular hyperplasia CT findings with emphasis on multiphasic helical CT in 78 patients Radiology 219 2001 61 68
16. E.L. Bressler, M.B. Alpern, G.M. Glazer Hypervascular hepatic metastases CT evaluation Radiology 162 1987 49 51
17. R.H. Cohan, L.S. Sherman, M. Korobkin Renal masses Assessment of corticomedullary-phase and nephrographic-phase CT scans Radiology 196 1995 445 451
18. R.A. DuBrow, C.L. David, H.I. Libshitz Detection of hepatic metastases in breast cancer the role of nonenhanced and enhanced CT scanning J Comput Assist Tomogr 14 1990 366 369
19. W.D. Foley, L.L. Berland, T.L. Lawson Contrast enhancement technique for dynamic hepatic computed tomographic scanning Radiology 147 1983 797 803
20. W.D. Foley, T.A. Mallisee, M.D. Hohenwalter Multiphase hepatic CT with a multirow detector CT scanner Am J Roentgenol 175 2000 679 685
21. P.R. Garrett, S.L. Meshkov, G.S. Perlmutter Oral contrast agents in CT of the abdomen Radiology 153 1984 545 546
22. L. Grazioli, M.P. Federle, G. Brancatelli Hepatic adenomas Imaging and pathologic findings Radiographics 21 2001 877 892
23. E.L. Hanninen, T.J. Vogl, R. Felfe Detection of focal liver lesions at biphasic spiral ct randomized double-blind study of the effect of iodine concentration in contrast materials Radiology 216 2000 403 409
24. J.P. Heiken, J.A. Brink, B.L. McClennan Dynamic contrast-enhanced CT of the liver Comparison of contrast medium injection rates and uniphasic and biphasic injection protocols Radiology 187 1993 327 331
25. B.R. Herts, D.M. Coll, A.C. Novick Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys Am J Roentgenol 178 2002 367 372
26. G.M. Israel, M.A. Bosniak How I do it Evaluating renal masses Radiology 236 2005 441 450
27. I.R. Kamel, M.A. Choti, K.M. Horton Surgically staged focal liver lesions Accuracy and reproducibility of dual-phase helical CT for detection and characterization Radiology 227 2003 752 757
28. M.T. Keogan, V.G. McDermott, E.K. Paulson Pancreatic malignancy Effect of dual-phase helical CT in tumor detection and vascular opacification Radiology 205 1997 513 518
29. L. Kopka, M. Funke, U. Fischer Parenchymal liver enhancement with bolus-triggered helical CT Preliminary clinical results Radiology 195 1995 282 284
30. D.S. Lu, S. Vedantham, R.M. Krasny Two-phase helical CT for pancreatic tumors pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures Radiology 199 1996 697 701
31. J.H. Oliver 3rd, R.L. Baron Helical biphasic contrast-enhanced CT of the liver Technique, indications, interpretation, and pitfalls Radiology 201 1996 1 14
32. D.H. Sheafor, M.T. Keogan, D.M. DeLong Dynamic helical CT of the abdomen prospective comparison of pre- and postprandial contrast enhancement Radiology 206 1998 359 363
33. P.M. Silverman, S.C. Roberts, I. Ducic Assessment of a technology that permits individualized scan delays on helical hepatic CT A technique to improve efficiency in use of contrast material AJR Am J Roentgenol 167 1996 79 84
34. D.H. Szolar, F. Kammerhuber, S. Altziebler Multiphasic helical CT of the kidney increased conspicuity for detection and characterization of small (< 3-cm) renal masses Radiology 202 1997 211 217
35. O. Vignaux, P. Legmann, J. Coste Cirrhotic liver enhancement on dual-phase helical CT Comparison with noncirrhotic livers in 146 patients AJR Am J Roentgenol 173 1999 1193 1197
36. G. Brix, U. Lechel, G. Glatting Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations J Nucl Med 46 2005 608 613
37. Y.Y. Yau, W.S. Chan, Y.M. Tam Application of intravenous contrast in PET/CT Does it really introduce significant attenuation correction error? J Nucl Med 46 2005 283 291
38. G. Ravizzini, M. Nguyen, D.M. Schuster Central line injection artifact simulating paratracheal adenopathy on FDG PET imaging Clin Nucl Med 29 2004 735 737
39. G.W. Goerres, T.F. Hany, E. Kamel Head and neck imaging with PET and PET/CT artefacts from dental metallic implants Eur J Nucl Med Mol Imaging 29 2002 367 370
40. G. Antoch, L.S. Freudenberg, T. Egelhof Focal tracer uptake a potential artifact in contrast-enhanced dual-modality PET/CT scans J Nucl Med 43 2002 1339 1342
41. T. Blodgett, M.B. Fukui, C.H. Snyderman Combined PET-CT in the head and neck: Part I. Physiologic, altered physiologic, and artifactual FDG uptake Radiographics 25 2005 897 912
42. A. Bockisch, T. Beyer, G. Antoch Positron emission tomography/computed tomography - imaging protocols, artifacts, and pitfalls Mol Imaging Biol 6 2004 188 199
43. G. Antoch, H. Kuehl, J. Kanja Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts Introduction and evaluation Radiology 230 2004 879 885
44. S.A. Nehmeh, Y.E. Erdi, H. Kalaigian Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT J Nucl Med 44 2003 1940 1944
45. C. Cohade, R.L. Wahl Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements Semin Nucl Med 33 2003 228 237
46. D. Visvikis, D.C. Costa, I. Croasdale CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET Eur J Nucl Med Mol Imaging 30 2003 344 353
47. C. Cohade, M. Osman, Y. Nakamoto Initial experience with oral contrast in PET/CT Phantom and clinical studies J Nucl Med 44 2003 412 416
48. E.V. Dizendorf, V. Treyer, G.K. Von Schulthess Application of oral contrast media in coregistered positron emission tomography-CT AJR Am J Roentgenol 179 2002 477 481
49. J.P. Carney, T. Beyer, D. Brasse Clinical PET/CT scanning using oral CT contrast agents J Nucl Med 45 2002 57
50. R. de Juan, B. Seifert, T. Berthold Clinical evaluation of a breathing protocol for PET/CT Eur Radiol 14 2004 1118 1123
51. G.W. Goerres, C. Burger, M.R. Schwitter PET/CT of the abdomen Optimizing the patient breathing pattern Eur Radiol 13 2003 734 739
52. M.M. Osman, C. Cohade, Y. Nakamoto Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT Eur J Nucl Med Mol Imaging 30 2003 603 606
53. W. Romer, M. Chung, A. Chan Single-detector helical CT in PET-CT Assessment of image quality AJR Am J Roentgenol 182 2004 1571 1577
54. M.M. Osman, C. Cohade, Y. Nakamoto Clinically significant inaccurate localization of lesions with PET/CT frequency in 300 patients J Nucl Med 44 2003 240 243
55. R.E. Coleman, D. Delbeke, M.J. Guiberteau Concurrent PET/CT with an integrated imaging system intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance J Nucl Med 46 2005 1225 1239